Cedars-Sinai Comprehensive Transplant Center is a clinical research site located in Los Angeles, California, United States 90048.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Cedars-Sinai Comprehensive Transplant Center has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Non-alcoholic Fatty Liver Disease, Liver Cirrhosis, Nonalcoholic Fatty Liver Disease.
Sponsors: Celgene, Pfizer, European Foundation for Study of Chronic Liver Failure.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cedars-Sinai Comprehensive Transplant Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cedars-Sinai Comprehensive Transplant Center has 6 clinical trials on record, with 1 currently active. Their work covers Non-alcoholic Fatty Liver Disease, Liver Cirrhosis, Nonalcoholic Fatty Liver Disease.
Yes — Cedars-Sinai Comprehensive Transplant Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.